Back to Search Start Over

Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action.

Authors :
Fernández-Montalván AE
Berger M
Kuropka B
Koo SJ
Badock V
Weiske J
Puetter V
Holton SJ
Stöckigt D
Ter Laak A
Centrella PA
Clark MA
Dumelin CE
Sigel EA
Soutter HH
Troast DM
Zhang Y
Cuozzo JW
Keefe AD
Roche D
Rodeschini V
Chaikuad A
Díaz-Sáez L
Bennett JM
Fedorov O
Huber KVM
Hübner J
Weinmann H
Hartung IV
Gorjánácz M
Source :
ACS chemical biology [ACS Chem Biol] 2017 Nov 17; Vol. 12 (11), pp. 2730-2736. Date of Electronic Publication: 2017 Oct 24.
Publication Year :
2017

Abstract

ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types. Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells. These features qualify BAY-850 as a chemical probe to explore ATAD2 biology.

Details

Language :
English
ISSN :
1554-8937
Volume :
12
Issue :
11
Database :
MEDLINE
Journal :
ACS chemical biology
Publication Type :
Academic Journal
Accession number :
29043777
Full Text :
https://doi.org/10.1021/acschembio.7b00708